140 related articles for article (PubMed ID: 14526228)
21. Effects of adenoviral-mediated gene transfer of interleukin-10, interleukin-4, and transforming growth factor-beta on the survival of axotomized retinal ganglion cells.
Koeberle PD; Gauldie J; Ball AK
Neuroscience; 2004; 125(4):903-20. PubMed ID: 15120851
[TBL] [Abstract][Full Text] [Related]
22. Adenoviral expression of a transforming growth factor-beta1 antisense mRNA is effective in preventing liver fibrosis in bile-duct ligated rats.
Arias M; Sauer-Lehnen S; Treptau J; Janoschek N; Theuerkauf I; Buettner R; Gressner AM; Weiskirchen R
BMC Gastroenterol; 2003 Oct; 3():29. PubMed ID: 14565855
[TBL] [Abstract][Full Text] [Related]
23. Activity-dependent release of transforming growth factor-beta in a neuronal network in vitro.
Lacmann A; Hess D; Gohla G; Roussa E; Krieglstein K
Neuroscience; 2007 Dec; 150(3):647-57. PubMed ID: 17997227
[TBL] [Abstract][Full Text] [Related]
24. Neuroprotection against focal ischemic brain injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone.
Luo Y; Yin W; Signore AP; Zhang F; Hong Z; Wang S; Graham SH; Chen J
J Neurochem; 2006 Apr; 97(2):435-48. PubMed ID: 16539667
[TBL] [Abstract][Full Text] [Related]
25. iNOS-derived NO and nox2-derived superoxide confer tolerance to excitotoxic brain injury through peroxynitrite.
Kawano T; Kunz A; Abe T; Girouard H; Anrather J; Zhou P; Iadecola C
J Cereb Blood Flow Metab; 2007 Aug; 27(8):1453-62. PubMed ID: 17293848
[TBL] [Abstract][Full Text] [Related]
26. Erythropoietin attenuates lipopolysaccharide-induced white matter injury in the neonatal rat brain.
Kumral A; Baskin H; Yesilirmak DC; Ergur BU; Aykan S; Genc S; Genc K; Yilmaz O; Tugyan K; Giray O; Duman N; Ozkan H
Neonatology; 2007; 92(4):269-78. PubMed ID: 17627093
[TBL] [Abstract][Full Text] [Related]
27. Role of cytokine gene polymorphism and hepatic transforming growth factor beta1 expression in recurrent hepatitis C after liver transplantation.
Ben-Ari Z; Pappo O; Druzd T; Sulkes J; Klein T; Samra Z; Gadba R; Tambur AR; Tur-Kaspa R; Mor E
Cytokine; 2004 Jul; 27(1):7-14. PubMed ID: 15207246
[TBL] [Abstract][Full Text] [Related]
28. Remission of collagen-induced arthritis is associated with high levels of transforming growth factor-beta expression in the joint.
Marinova-Mutafchieva L; Gabay C; Funa K; Williams RO
Clin Exp Immunol; 2006 Nov; 146(2):287-93. PubMed ID: 17034581
[TBL] [Abstract][Full Text] [Related]
29. Anti-macrophage migration inhibitory factor reduces transforming growth factor-beta 1 expression in experimental IgA nephropathy.
Leung JC; Chan LY; Tsang AW; Liu EW; Lam MF; Tang SC; Lai KN
Nephrol Dial Transplant; 2004 Aug; 19(8):1976-85. PubMed ID: 15187193
[TBL] [Abstract][Full Text] [Related]
30. Role of transforming growth factor-beta1 (TGF-beta1) in endotoxin-induced hepatic failure after extensive hepatectomy in rats.
Yoshimoto N; Togo S; Kubota T; Kamimukai N; Saito S; Nagano Y; Endo I; Sekido H; Nagashima Y; Shimada H
J Endotoxin Res; 2005; 11(1):33-9. PubMed ID: 15826376
[TBL] [Abstract][Full Text] [Related]
31. Preconditioning-induced ischemic tolerance stimulates growth factor expression and neurogenesis in adult rat hippocampus.
Naylor M; Bowen KK; Sailor KA; Dempsey RJ; Vemuganti R
Neurochem Int; 2005 Dec; 47(8):565-72. PubMed ID: 16154234
[TBL] [Abstract][Full Text] [Related]
32. Induction of the alpha(1)-antichymotrypsin gene in the brain associated with TGF-beta1 deficiency or systemic administration of endotoxin.
Saito H; Shultz LD; Sinha M; Papaconstantinou J
Biochem Biophys Res Commun; 1999 Sep; 263(2):270-5. PubMed ID: 10491283
[TBL] [Abstract][Full Text] [Related]
33. [Does transforming growth factor-beta (TGF-beta) act as a neuroprotective agent in cerebral ischemia?].
Docagne F; Ali C; Lesne S; Nicole O; MacKenzie ET; Buisson A; Vivien D
J Soc Biol; 2003; 197(2):145-50. PubMed ID: 12910629
[TBL] [Abstract][Full Text] [Related]
34. Histopathologic amelioration of fibroproliferative change in rat irradiated lung using soluble transforming growth factor-beta (TGF-beta) receptor mediated by adenoviral vector.
Nishioka A; Ogawa Y; Mima T; Jin YJ; Sonobe H; Kariya S; Kubota K; Yoshida S; Ueno H
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1235-41. PubMed ID: 15001268
[TBL] [Abstract][Full Text] [Related]
35. Transforming growth factor beta 1 induces neointima formation through plasminogen activator inhibitor-1-dependent pathways.
Otsuka G; Agah R; Frutkin AD; Wight TN; Dichek DA
Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):737-43. PubMed ID: 16373605
[TBL] [Abstract][Full Text] [Related]
36. Protection of erythropoietin on experimental spinal cord injury by reducing the expression of thrombospondin-1 and transforming growth factor-beta.
Fang XQ; Fang M; Fan SW; Gu CL
Chin Med J (Engl); 2009 Jul; 122(14):1631-5. PubMed ID: 19719963
[TBL] [Abstract][Full Text] [Related]
37. Reduced expression of transforming growth factor beta 1 exacerbates pathology in an experimental asthma model.
Scherf W; Burdach S; Hansen G
Eur J Immunol; 2005 Jan; 35(1):198-206. PubMed ID: 15593298
[TBL] [Abstract][Full Text] [Related]
38. SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo.
Uhl M; Aulwurm S; Wischhusen J; Weiler M; Ma JY; Almirez R; Mangadu R; Liu YW; Platten M; Herrlinger U; Murphy A; Wong DH; Wick W; Higgins LS; Weller M
Cancer Res; 2004 Nov; 64(21):7954-61. PubMed ID: 15520202
[TBL] [Abstract][Full Text] [Related]
39. Pathway and gene ontology based analysis of gene expression in a rat model of cerebral ischemic tolerance.
Feng Z; Davis DP; Sásik R; Patel HH; Drummond JC; Patel PM
Brain Res; 2007 Oct; 1177():103-23. PubMed ID: 17916339
[TBL] [Abstract][Full Text] [Related]
40. alpha2HS-glycoprotein, an antagonist of transforming growth factor beta in vivo, inhibits intestinal tumor progression.
Swallow CJ; Partridge EA; Macmillan JC; Tajirian T; DiGuglielmo GM; Hay K; Szweras M; Jahnen-Dechent W; Wrana JL; Redston M; Gallinger S; Dennis JW
Cancer Res; 2004 Sep; 64(18):6402-9. PubMed ID: 15374947
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
